'Cardiovascular events' diaporamas de présentation

Ca++, PO4, PTH & VIT D

Ca++, PO4, PTH & VIT D. Calcium, Phosphorus & Vitamin D In Chronic Renal Failure By Dr. Rick Hiller. Phosphorus Measurement and Balance. Normal concentration between 2.5 and 4.5 mg/dl.

1.03k views • 81 slides

What do we know about how evidence of harm and benefit is communicated in other countries?

509 views • 42 slides

Edith A. Perez, MD Director, Cancer Clinical Study Unit Mayo Clinic Jacksonville, Florida

Welcome and Introductions. Edith A. Perez, MD Director, Cancer Clinical Study Unit Mayo Clinic Jacksonville, Florida. The Early Use of Adjuvant Aromatase Inhibitors for Early Breast Cancer: New Contributions from the BIG 1-98 Letrozole Trial. John F. Forbes, MB, BS, MS, FRACS

518 views • 40 slides

Wood Smoke and Health August 23, 2007

Wood Smoke and Health August 23, 2007. Wood Smoke and Health. Judy Bardin, ScD Wood Smoke Work Group August 23, 2007 Dept. of Ecology NW Regional Office. Composition of Wood Smoke. Gases and fine particles suspended in air Visible and invisible components Inhalable particulate matter

466 views • 31 slides

Presented By Amy Abernethy at 2014 ASCO Annual Meeting

Managing Comorbidities In Oncology: <br />A multisite randomized controlled trial of continuing vs.<br />discontinuing statins in the setting of life-limiting illness. Presented By Amy Abernethy at 2014 ASCO Annual Meeting. Slide 2. Presented By Amy Abernethy at 2014 ASCO Annual Meeting.

496 views • 30 slides

The concept of Diabetes & CV risk: A lifetime risk challenge

Cardio Diabetes Master Class European chapter Munich, Germany May 6-8, 2011. The concept of Diabetes & CV risk: A lifetime risk challenge. RAS blockade in the real world: Clinical lessons from recent trials. Presentation topic. Slide lecture prepared and held by:. Peter Meredith PhD

411 views • 29 slides

Chronic Kidney Disease: Proposed Revisions to the ICD-9-CM Classification

Chronic Kidney Disease: Proposed Revisions to the ICD-9-CM Classification. Lesley Stevens MD Tufts-New England Medical Center National Kidney Foundation. Objectives. Kidney Failure Stages of Chronic Kidney Disease Definition and Classification of CKD GFR Proteinuria Etiology

783 views • 24 slides

Cardiac Rehabilitation (CR) in General Practice

624 views • 24 slides

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.

321 views • 24 slides

The Chemical Differences Between EPA and DHA

The Chemical Differences Between EPA and DHA. Lipid Effects of Drug Classes in Dyslipidemia and Hypertriglyceridemia. Icosapent Ethyl (Pure EPA) Median Placebo-Adjusted Change From Baseline for Efficacy End Points. Select Omega -3 Outcomes Studies.

306 views • 23 slides

Inflammation = Thrombosis

660 views • 20 slides

Aspirin An Update on its Use for Primary Prevention of Cardiovascular Events in People with Diabetes

Aspirin An Update on its Use for Primary Prevention of Cardiovascular Events in People with Diabetes . Joseph M. Bumgarner, MD Internal Medicine, PGY-1 ACC Noon Conference November 24, 2010. Questions to Consider.

720 views • 20 slides

Nocturia: Time to wake up to the seriousness of the problem

Nocturia: Time to wake up to the seriousness of the problem. R. ROSEN 1 , V. KUPELIAN 1 , and T. HOLM-LARSEN 2 1 New England Research Institutes, Watertown, Massachusetts, USA; 2 University of Copenhagen, Denmark and The Right Value Story, Copenhagen, Denmark. Absolutely!

336 views • 20 slides

Alicia Williams 2012 PharmD Candidate Mercer University COPHS July 7, 2011

Risk of Serious Cardiac Events in Older Adults Using Antipsychotic Agents Sandhya Mehta, MS; Hua Chen, MD, PhD; Michael Johnson, PhD; and Rajender R. Aparasu, MPharm, PhD Am J Geriatr Pharmacother. 2011; 9: 120-132. Alicia Williams 2012 PharmD Candidate Mercer University COPHS July 7, 2011.

377 views • 19 slides

Estimated GFR Based on Creatinine and Cystatin C

Estimated GFR Based on Creatinine and Cystatin C. Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA. Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869, UO1 DK 067651 and UO1 DK 35073. . Background.

1.58k views • 18 slides

Chapter 56

Chapter 56. Hematopoietic Agents. Hematopoietic Agents. Process by which blood cells and platelets are produced Types Hematopoietic growth factor Erythropoietic (RBCs) Leukopoietic (WBCs) Thrombopoietic growth factor Oprelvekin (platelets). Erythropoietic Growth Factors.

415 views • 15 slides

Weng TC, et al. J Clin Pharm Ther 2010;35:139-51

Weng TC, et al. J Clin Pharm Ther 2010;35:139-51. Baseline characteristics of statin studies with paired-comparisons. Weng TC, et al. J Clin Pharm Ther 2010;35:139-51. Comparisons of the lipid lowering effect of different statins: LDL. Weng TC, et al. J Clin Pharm Ther 2010;35:139-51.

329 views • 10 slides

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial.

250 views • 10 slides

Maximum home b lood pressure: a novel indicator of target-organ damage in hypertension

Maximum home b lood pressure: a novel indicator of target-organ damage in hypertension. B lood pressure variability has recently been shown to be a strong predictor of stroke and cardiovascular events, independently of the mean systolic blood pressure level. 1

174 views • 4 slides

Tang WHW, N Engl J Med 2013; 368:1575-1584

Intestinal Microbial Metabolism and CV Risk More adverse cardiovascular events at higher (quartiles of) TMAO levels. Tang WHW, N Engl J Med 2013; 368:1575-1584.

131 views • 1 slides